OncoCyte Corp
OCX
Delayed Nyse MKT - 10/20 10:00:00 pm
6.5USD
+2.36%
Upcoming events

- No events available -

Past Events
08/14/17 | 10:30pmInterim 2017 Earnings Call
08/14/17Interim 2017 Earnings Release
06/15/17Annual General Meeting
05/22/17 | 10:30pmQ1 2017 Earnings Call
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread



0,06
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-10,8
-10,6
-1,4%

-15,5
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-11,1
-11,0
-1,5%

-15,9
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-11,2
-11,1
-0,77%

-16,4
Net income
Million $
Released
Forecast
Spread
-11,2
-11,1
-0,77%

-16,4
EPS
 $
Released
Forecast
Spread
-0,42
-0,35
-20%

-0,55
Announcement Date02/27/2017
Quarterly / Semiannualy publications
Quarterly resultsQ2
2017
Q3
2017 (e)
Sales
Million $
Released
Forecast
Spread




Operating income (EBITDA)
Million $
Released
Forecast
Spread
-3,45
-3,40
-1,5%

-3,90
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-3,59
-3,68
2,3%

-3,83
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-3,80
-3,87
1,7%

-3,88
Net income
Million $
Released
Forecast
Spread
-3,80
-3,87
1,7%

-3,88
EPS
 $
Released
Forecast
Spread
-0,13
-0,12
-8,3%

-0,13
Announcement Date08/14/2017